Amgen (Amgen Technology Ireland)

Lobbying Organisation Amgen

Date published 17 Jan, 2025

Relevant Matter Legislation

Public Policy Area Health

Period 1 Sep, 2024 to 31 Dec, 2024

Specific Details Discussed EU competitiveness for biopharmaceutical industry investments at ALDE 2024 party conference roundtable; discussed Biotech Act, EU Pharma Legislation, and Draghi Report.

Intended results Participate in hosted roundtable event

Name of person primarily responsible for lobbying on this activity Nicholas Cosenza

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Event / Reception (1)

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Billy Kelleher MEP (European Parliament)